L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)

Figure 3

Plasma concentrations (a) and urine excretion rates (b) of ADMA in children with haemolytic-uraemic syndrome (HUS, 𝑛) and in healthy children (controls, 𝑚). Horizontal bars indicate the mean values. Plasma ADMA concentrations were insignificantly lower in HUS as compared with controls (𝑃=0.32; 𝑛=12, 𝑚=12). Urinary excretion of ADMA was significantly lower in HUS as compared with controls (𝑃=0.019; 𝑛=5, 𝑚=9).

(a)

(b)